CiDrep Platform – An Integrated Genomics Informatics Pipeline Platform
A platform to massively speed up genomic analysis, annotation and filtering of variants from hours to minutes
CiDrep™ (Clinical Informatics and Disease Registry Enterprise Platform) power next-generation sequencing (NGS) workflows from analysis, annotation, filtering to variant report with accessible, scalable and compliant genomics analysis for your laboratory. CiDrep™ is a powerful pipeline toolkit that make it easier for researchers to analyze exome, whole genomes, conduct human disease studies and identify/confirm disease-causing variants in patients. Powered (by IBM) and designed and build on IBM Cloud platform specifically for genomics and other bioinformatics data-intensive services, using IBM Spectrum LSF® and IBM Spectrum Scale™ to support high-throughput genomics work.
CiDrep™ – Analyzing, Annotating and Filtering Variants.
Healthcare and life science organizations are increasingly looking for collaboration tools to enable scientists and clinicians to work more closely together to bring new diagnostics tools to patient care quickly than ever before. Our Pipeline will help both researchers and clinicians to analyze, recognize and actualize insights from disease variants data that can further accelerate critical scientific research and patient care.
CiDrep™ Workflow Overview
- Data Sourcing, Mapping and Refinery
- Tuning, Duplication and Trace
- Variant Discovery, Genotyping and Annotation
- Disease Specific Variant Extraction
- Disease Variant Data Clinical Repository
CiDrep™ Genomic Data Analysis
CiDrep™ provides a powerful point of access to established laboratory genomic tests in hospitals and medical research centers for a range of diseases including inflammatory bowel disease (IBD), Ulcerative colitis (UC) and other pediatric conditions. By developing a scientific informatics platform needed to deliver clinically relevant disease variants results, CiDrep ™ NGS pipeline is delivering genomically enhanced medical results—cost-effective genomics testing that’s easy for any clinician to assist with patient care.
Genomics testing has the potential to revolutionize patient care if it can be offer broadly to all patients that might need it. As such, we developed an integrated NGS data analysis, collaborative and workflow registry system for human disease-variant. Our platform (CiDrep™) provides a powerful point of access and use case to established laboratory within hospitals and medical research centers for a range of diseases including IBD, UC, other pediatric conditions and cancer.